RxDoctor Payments Data

Kristine van Winkle

Pediatrics · Noblesville, INNPI 1285924712

Payments from drug & device makers

$616in general payments, 2019–2025

Across 33 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$92
  • AbbVie$89
  • Lilly USA, LLC$69
  • Novo Nordisk$64
  • Abbott$64
  • AstraZeneca$43
  • plus $195 from 9 others

What the payments were for

  • Food & beverage$616100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$616 in reported general payments places this provider in the 70th percentile of 964 pediatrics providers in Indiana.

See all pediatrics providers in Indiana

Medicare billing

Part B allowed, 2024
$38,454
Medicare patients
128
Services billed
412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$53,561
MounjaroTirzepatide36$37,357
JanuviaSitagliptin Phosphate29$25,072
JardianceEmpagliflozin22$21,916
EliquisApixaban14$13,262
LinzessLinaclotide12$11,351
MyrbetriqMirabegron14$8,808
Tresiba Flextouch U-200Insulin Degludec11$7,525
Tresiba Flextouch U-100Insulin Degludec11$6,233
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,380
ShingrixVaricella-Zoster Ge/As01b/Pf21$4,636
Gabapentin108$1,841
Atorvastatin Calcium205$1,431
Omeprazole109$1,415
SynthroidLevothyroxine Sodium18$1,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$64$53,56142 claims
Lilly USA, LLCMounjaro$69$37,35736 claims
PfizerEliquis$30$13,26214 claims
AbbVieLinzess, Synthroid$89$12,62030 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 964 pediatrics providers in Indiana.

Other pediatrics in Noblesville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →